We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
-6.2%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$2.11B
AUM Growth
+$179M
Cap. Flow
+$345M
Cap. Flow %
16.36%
Top 10 Hldgs %
73.49%
Holding
53
New
4
Increased
8
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
EXAI
Exscientia Plc American Depositary Shares
EXAI
+$275M
2
BABA icon
Alibaba
BABA
+$41.7M
3
IOBT
IO Biotech
IOBT
+$31.7M
4
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
+$14.6M
5
MQ icon
Marqeta
MQ
+$9.88M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$18.7M
2
BN icon
Brookfield
BN
+$10.1M
3
FLXN
Flexion Therapeutics, Inc.
FLXN
+$8.56M
4
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
+$3.46M
5
AFIB
Acutus Medical Inc
AFIB
+$2.25M

Sector Composition

Rank Sector Weight
1 Healthcare 56.57%
2 Financials 8.35%
3 Technology 8.08%
4 Consumer Discretionary 2.82%
5 Communication Services 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$652B
$467M 22.11%
1,933,900
– –
EXAI
2
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$259M 12.24%
+13,086,600
New +$275M
BN icon
3
Brookfield
BN
$102B
$176M 8.35%
5,420,233
-319,146
-6% -$10.1M
AAPL icon
4
Apple
AAPL
$5.04T
$163M 7.73%
918,879
-118,525
-11% -$18.7M
BSX icon
5
Boston Scientific
BSX
$69B
$147M 6.97%
3,463,577
– –
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$97.2M 4.6%
2,050,446
– –
EWTX icon
7
Edgewise Therapeutics
EWTX
$4.28B
$85.4M 4.04%
5,587,207
– –
BABA icon
8
Alibaba
BABA
$277B
$59.5M 2.82%
500,827
+286,000
+133% +$41.7M
CYT
9
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$55M 2.61%
4,840,413
– –
NKTX icon
10
Nkarta
NKTX
$153M
$42.9M 2.03%
2,793,864
– –
MIRM icon
11
Mirum Pharmaceuticals
MIRM
$6.7B
$39M 1.85%
2,445,147
– –
INGN icon
12
Inogen
INGN
$175M
$36.5M 1.73%
1,072,735
-6,585
-0.6% -$239K
ALGS icon
13
Aligos Therapeutics
ALGS
$25.9M
$31M 1.47%
104,583
– –
FOLD
14
DELISTED
Amicus Therapeutics
FOLD
$29.6M 1.4%
2,560,211
– –
OKUR
15
OnKure Therapeutics
OKUR
$162M
$29.3M 1.39%
343,038
– –
CABO icon
16
Cable One
CABO
$244M
$28M 1.33%
15,873
– –
VERV
17
DELISTED
Verve Therapeutics
VERV
$25.8M 1.22%
700,000
+100,000
+17% +$4.2M
BOLT icon
18
Bolt Biotherapeutics
BOLT
$7.4M
$22.1M 1.05%
225,200
– –
BPMC
19
DELISTED
Blueprint Medicines
BPMC
$21.1M 1%
197,000
– –
IOBT
20
DELISTED
IO Biotech
IOBT
$21M 0.99%
+3,277,932
New +$31.7M
SPRB
21
Spruce Biosciences
SPRB
$114M
$20.1M 0.95%
60,191
– –
INSM icon
22
Insmed
INSM
$22.5B
$19M 0.9%
695,840
– –
LVTX
23
DELISTED
LAVA Therapeutics
LVTX
$18.3M 0.87%
3,327,312
– –
VECT
24
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$17.3M 0.82%
3,522,019
– –
MIST icon
25
Milestone Pharmaceuticals
MIST
$127M
$16.6M 0.78%
2,530,585
– –
1
2 3

Similar funds

HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Novo Holdings A/S's Q4 2021 Portfolio in Review

As of Q4 2021, Novo Holdings A/S held 53 positions worth $2.11B, up 9.2% from $1.93B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Novo Holdings A/S deployed $345M of net new capital in Q4 2021, opening 4 new positions and adding to 8 existing holdings. Its largest new stake was Exscientia Plc American Depositary Shares: 13,086,600 shares worth $259M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 57% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Apple, an estimated $18.7M trimmed.

  • Novo Holdings A/S's largest Q4 2021 buy was Exscientia Plc American Depositary Shares: 13,086,600 shares worth $259M.
  • Novo Holdings A/S added most to Alibaba in Q4 2021, an estimated $41.7M increase.
  • Novo Holdings A/S's biggest Q4 2021 reduction was Apple, cutting an estimated $18.7M.
  • Novo Holdings A/S fully exited Flexion Therapeutics, Inc. in Q4 2021, selling an estimated $8.56M.
  • Novo Holdings A/S's ten largest holdings make up 73% of its $2.11B portfolio in Q4 2021.
  • Novo Holdings A/S opened 4 new positions and closed 5 in Q4 2021.
  • Novo Holdings A/S's portfolio value rose 9.2% quarter-over-quarter to $2.11B.

Based on Novo Holdings A/S's 13F filing for Q4 2021, filed 14 Feb 2022.